Commercial opportunities and ethical pitfalls in personalized medicine: a myriad of reasons to revisit the Myriad Genetics saga

So, D., Joly, Y., “Commercial opportunities and ethical pitfalls in personalized medicine: a myriad of reasons to revisit the Myriad Genetics saga” 11:2 (2013) Pharmacogenomics and Personalized Medicine 98-109.

This content has been updated on January, 18 2016 at 12 h 56 min.